Morgan Stanley Maintains Overweight on Emerson Electric

Loading...
Loading...
Morgan Stanley remains Overweight-rated on Emerson Electric
EMR
as the company releases quarterly EPS that were largely in line with expectations. Morgan Stanley comments, "EMR reported $0.50 EPS as expected, although there is not much to like in these numbers, with core growth declines in all segments aside from Tools & Storage. The good news is that it was well flagged and so expected, with management only modestly adjusting down its FY12 sales outlook (by 1ppt), and provided a formal EPS range of $3.45-3.60 - an adjustment of $0.05-0.10 to the prior framework, of which $0.02-0.04 is being driven by higher restructuring investment of $125m." EMR closed at $53.37 a share on Monday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetReiterationIntraday UpdateAnalyst RatingsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...